European Leukemia Trial Registry
Trial: ALCANTARA

More Details
Title Phase 2 Trial of Blinatumomab vs Investigator's Choice of Chemotherapy in Patients With Relapsed or Refractory ALL
Scientific Title A Phase 2 Single Arm, Multicenter Trial to Evaluate the Efficacy of the BiTE Antibody Blinatumomab in Adult Subjects With Relapsed/Refractory Philadelphia Positive B-precursor Acute Lymphoblastic Leukemia (Alcantara Study)
Short Title ALCANTARA
Trialgroup NN
Type of Trial multicentric, single-group, open-label
Disease Acute lymphoblastic leukemia(ALL) Ph/BCR ABL +
Age >= 18 years
Status Temporary on hold
Start of Recruitment 20.12.2013
Contactperson

Scientific Contact
Topp, Prof. Dr. med., Max
Tel: +49 (0)931 201 70490
Fax: +49 (0)931 201 70841
Email: topp_m@klinik.uni-wuerzburg.de

Scientific Contact
Gökbuget, Dr. med., Nicola
Tel: +49 (0)69 6301-6366
Fax: +49 (0)69 6301- 7463
Email: goekbuget@em.uni-frankfurt.de

Shortprotocol Shortprotocol
created 15.04.2014 Johannes Kraus
changed 14.09.2015 Zena Krüger
© ELIC European Leukemia Information Center | no responsibility is taken for correctness and completeness of this information | www.leukemia-net.org | elic@leukemia-net.org